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Aim: To evaluate the function of cochlear outer hair-cells 
under the influence of extra-corporeal circulation and mo-
derate hypothermia during cardiac surgery. Study Design: 
Prospective clinical study. Methods: Distortion-product 
otoacoustic emissions (DPOAE) were registered before 
surgery, immediately after general anesthesia induction, 
during extra-corporeal circulation with moderate hypother-
mia and after the surgical procedure. Results: Comparison 
of response-amplitudes before and after surgery and before 
and after general anesthesia initiation did not demonstrate 
statistical difference. Comparison of amplitudes before and 
after extra-corporeal circulation with moderate hypothermia 
demonstrated a statistically significant decrease in responses 
amplitudes during hypothermia. Conclusions: The ampli-
tudes of DPOAE decreased during moderate hypothermia 
induced during extra-corporeal circulation.
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INTRODUCTION
Otology is faced with a new challenge this mil-
lennium: the study of the inner ear. This portion of the 
auditory apparatus has posed the largest obstacles to 
reaching accurate diagnosis and effective treatment. The 
outer hair cells (OHC) in the cochlea have been exten-
sively analyzed in areas such as cochlear microfonism, 
sound amplification and frequency discrimination1. One 
of the methods to study the OHC is recording otoacoustic 
emissions (OAE)1,2.
Studies have reported the marked susceptibility of 
the OHC to hypovolemia and/or ischemia3. In order to 
further investigate the matter, we decided to look into 
distortion product otoacoustic emissions (DPOAE) during 
heart surgery with extracorporeal circulation (ECC) and 
hypothermia, an event where the risk of peripheral organ 
ischemia is high in spite of technological progress, as it 
changes the pulsating blood flow driven by the heart to a 
continuum produced by the machine. Additionally, during 
such procedures patients are usually submitted to moderate 
(28-29ºC) or deep (18ºC) hypothermia. This is the setting 
in which the study of ECC in situations of hypoperfusion 
and hypothermia becomes invaluable to better understand 
how these cells function under stressful circumstances.
The risk of sensorineural hearing loss after surgical 
procedures including ECC and hypothermia is estimated 
at 0.14% in the literature, a rate six times greater that the 
risk incurred in by the population in general4,5. Could 
DPOAE, as it mimics OHC, be utilized to monitor such 
risk? It has been established in the literature that hypo-
thermia impacts cochlear potential, spontaneous OAE and 
evoked transients, both in animal and human models6-12. 
However, there are no reports on altered DPOAE test re-
sults during hypothermia in humans. The purpose of this 
study is to assess the behavior of the OHC during heart 
surgery where ECC and moderate hypothermia are used 
through DPOAE.
MATERIALS AND METHODS
This study was approved by the Research Ethics 
Committee at our institution under permit 0592/02.
The protocol described below was instituted to 
study the behavior of DPOAEs in heart surgery patients 
submitted to moderate hypothermia. Before surgery, all 
patients were interviewed and asked about age, gender, 
place of birth, occupation, medical and audiological his-
tory; they also underwent a thorough otorhinolaryngolo-
gical examination. In order to qualify for the trial, patients 
had to have normal otorhinolaryngological findings, no 
auditory complaints, no previous history of acoustic trauma 
and/or exposure to noise, and be able to comprehend 
(either the patient of his/her legal representative) and sign 
an Informed Consent term.
Within four months, eighteen patients that would 
be operated on by the same team of heart surgeons and 
anesthesiologists were interviewed. One of these patients 
refused to participate in the trial, another had a perforated 
eardrum and was thus excluded, and two had their surge-
ries called off for clinical reasons. In all, fourteen patients 
were included in the trial (28 ears), ten males and four 
females. Their ages ranged between 26 and 62 years of 
age and averaged at 47.86 years (STD = 14.5 years).
Three consecutive DPOAE measurements were 
done on each ear by the patients’ beds, in a silent ho-
wever not acoustically insulated environment; this data 
series was named ’PRE’. During surgery DPOAE tests were 
done in two stages: after anesthesia - three consecutive 
measurements on each ear, data series ’ANESTHESIA’; 
and after ECC was in place with moderate hypothermia - 
three consecutive measurements on each ear, data series 
’HYPOTHERMIA’. Between three to five days after surgery, 
as the patients had been sent back to their beds, three 
additional consecutive measurements were done on each 
ear under the ’POST’ data series.
All surgical procedures were carried out in the 
same operating room by the same team of heart surgeons. 
Anesthesia was administered intravenously, without nitrous 
oxide. ECC was provided by a heart-lung Biomedica BEC 
2000 System® machine, a continuous flow system with 
roller head pumps, venous and arterial tubing, and mem-
brane oxygenator. The patients were anticoagulated and 
their bodily temperatures monitored with a pharyngeal 
thermometer.
For the DPOAE tests a portable Grason-Stadler Inc.® 
device with GSI-60 software was used, and the Darmuth 
Hitchcock Medical Center protocol by Musiek e Baran 
em 199713 adopted, with two tones L1 = L2 = 70 dB of 
sound pressure level (SPL) and f2/f1 = 1.22. The tests were 
analyzed using a ’DPgram’ by amplitude of response (A) 
of the distortion product (DP) in relation to background 
noise (BN). The measurement [A = DP - BN] in dB of SPL 
was obtained for frequency 2f1 - f2 in a total of 11 points 
corresponding to 531, 687, 843, 1093, 1375, 1750, 2187, 
2781, 3500, 4375 and 5500 Hz (called F1 to F11 respecti-
vely) related to the geometric average of f1 and f2 used to 
build the ’DPgram’. Occurrences of DPOAE were consi-
dered positive when ’A’ was equal to or greater than 3 dB 
SPL. Data series PRE, ANESTHESIA, HYPOTHERMIA, and 
POST were analyzed for each ear and each of the eleven 
points of the ’PDgram’ listed above (F1 to F11).
On each of the four series, three tests were done 
for each ear, but to be deemed valid for analysis purposes 
the following set of criteria was applied:
§ If two or three records were ’rejected’ by the de-
vice, the data was deemed ’invalid’ for analysis.
§ If at least two records were ’accepted’ by the 
device:
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•Two or three values of A ≥ 3 dB SPL - DPOAE 
present and the averages were calculated;
•Two or three values of A < 3 dB SPL - DPOAE 
absent.
With that, one average value was defined for each 
of the eleven points of the ’DPgram’ (F1 to F11) from 
the PRE, ANESTHESIA, HYPOTHERMIA, and POST data 
series. For descriptive statistics, all continuous variables 
were described in terms of average, standard deviation, 
variation amplitude, maximum and minimum values, me-
dian, upper and lower quartiles, skewness, kurtosis, and 
the Kolmogorov-Smirnov test.
In order to analyze the significance of the diffe-
rences found on each of the series and on each of the 
points of the ’DPgram’ (F1 to F11), the averages for both 
ears of the patients were observed. If only one of the ears 
provided for a valid record, the data from such ear was 
considered for analysis. When only two ranges of values 
were available, the ’Paired t-Test’ was used. When more 
than two ranges of values were observed, the ’one-way 
ANOVA’ and ’all pairwise multiple comparison procedures 
- Dunnett´s method’ were used to compare the PRE data 
series to all others (PRE x POST, PRE x ANESTHESIA, PRE 
x HYPOTHERMIA).
The possibility of performing parametric tests was 
assessed through the Kolmogorov-Smirnov Normality Test 
or variance equivalence test. When parametric tests could 
not be applied, logarithmic (Log10 e Ln) and squaring 
transformations were tried, and then again normality was 
tested. When impossibility prevailed, the comparison was 
done through Friedman’s Repeated Measures Analysis of 
Variance on Ranks. The cutoff point for significance was 
0.05. Statistical and graphic calculations were done on the 
following registered software: STATISTICA 4.5® (Statsoft, 
Inc. 1993) and SIGMA STAT 1.0® (Jandel Corporation, 
1993, 956245).
RESULTS
Chart 1 comprises the description of the DPOAE 
amplitudes for each point in the ’DPgram’ (F2 to F11) and 
each data series (PRE, ANESTHESIA, HYPOTHERMIA, and 
POST). F1 (531Hz) was not included, as no valid data was 
obtained for analysis. Data points also considered invalid 
for analysis: F2 ANESTHESIA, F2 HYPOTHERMIA, F3 
ANESTHESIA, F3 HYPOTHERMIA and F4 HYPOTHERMIA. 
A summary of the comparative analysis can be seen in 
Chart 2, including all statistically significant data. For each 
point in the ’DPgram’ a ’box plot’ was presented (with va-
lues expressed in dB SPL) (Graphs 1 to 10). By comparing 
data series PRE and POST, no differences were found for 
any of the points. Such absence of significance was also 
observed when comparing the PRE and ANESTHESIA 
data series. On the other hand, when comparing PRE and 
HYPOTHERMIA, reduced DPOAE amplitudes were found 
(p<0.05) for points F5 to F11, for which valid data points 
were available. Graph 11 shows the behavior of the avera-
ges on each of the frequencies for the PRE, ANESTHESIA, 
HYPOTHERMIA, and POST data series.
DISCUSSION
OAEs, described by Kemp in 197814, arise apparently 
in the OHC2,15,16 and possibly represent the rapid contrac-
tions of this cell group. They are acoustic phenomena of 
cochlear nature, which reverberate through the ossicles in 
the middle ear and are transmitted to the ear canal, where 
they can be captured through a microphone. This spurt 
of energy in the form of sound may occur spontaneously 
or in response to external auditory simulation. Although 
these cells contain actin and myosin filaments similar to 
those found in muscle cells, it is believed that the rapid 
contractions that produce OAEs do not stem from this 
mechanism. They occur in the absence of calcium, a ne-
cessary ion for actin and myosin to couple together and 
act as a contractile unit. Various explanations for the likely 
contraction mechanism in place have been discussed, 
such as the participation of the lateral cisterns17, cortical 
cytoskeleton15, and cell membrane proteins18.
Also in 1978, Kemp14 defined the cochlea as a non-
linear sound amplifier that intermodulates the pure tones 
used in the DPOAE tests and responds through a series 
of sounds in different frequencies, the most prevalent 
being the one corresponding to 2f1-f2, which was chosen 
to record the phenomenon. The precise site in the coch-
lea where DPOAEs are generated remains controversial. 
Lonsbury-Martin et al.19, Probst and Harris20, Beattie and 
Jones21 and Doyle et al.22 believe they originate in the 
cochlear region that corresponds to f2 or in the region 
that corresponds to the geometric average of f1 and f2. 
However, at least in animal models, other candidate sites 
have been discussed23. This controversy, however, does not 
reduce its application in the study of  the effect produced 
by ototoxic drugs24,25, noise induced auditory disorders26, 
inner ear diseases1, and other situations in which cochlear 
injury may occur27.
No acceptable DPOAE records were obtained at 
lower frequencies due to excessive background noise, a 
fact also reported and studied by other authors. Delgado 
et al.28 published a paper on the development of software 
to minimize the impact background noise when DPOAE 
tests are run in hospital settings without the ideal acoustic 
treatment. Internal (breathing, mastication, heartbeats) and 
external (environment) noise may contaminate the DPOAE 
test, mainly in lower frequencies. This was clearly observed 
in the ANESTHESIA and HYPOTHERMIA series, as the data 
was collected in the operating room where low frequencies 
simply could not be properly recorded. A similar situation 
was described by LeBourgeouis III et al.29.
Heart surgery with ECC modifies circulatory phy-
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Chart 1. Descriptive statistics for each point in the ’DPgram’ (F2 to F11) and each data series (PRE, ANESTHESIA, HYPOTHERMIA, and 
POST).
 n average STD max min median 25% 75% Skewness Kurtosis K-S P value
F2 PRE 8 11.8 2.22 15.5 10.00 11.0 10.42 13.1 1.329 -0.109 0.395 0.000578
F2 POST 9 11.2 1.13 13.8 10.00 11.0 10.69 11.4 1.467 2.998 0.265 0.068455
F3 PRE 14 10.7 2.15 15.7 7.75 10.6 9.00 11.7 0.699 0.878 0.108 0.808726
F3 POST 11 11.2 1.75 14.5 9.34 11.0 9.61 12.7 0.637 -0.726 0.177 0.406559
F4 PRE 14 11.08 4.16 20.8 5.00 10.29 9.17 12.34 1.169 1.650 0.223 0.056730
F4 ANES 9 11.49 3.83 17.9 6.50 10.50 9.00 14.56 0.544 -0.664 0.243 0.129124
F4 POST 12 11.29 3.94 20.0 4.50 10.71 9.66 11.84 0.891 1.836 0.246 0.043951
F5 PRE 14 11.94 3.10 17.0 8.16 11.17 9.34 14.67 0.793 -0.955 0.220 0.065731
F5 ANES 13 12.03 3.07 17.17 7.42 12.00 9.50 14.88 0.3030 -1.0161 0.147 0.553164
F5 HYPO 12 3.79 3.43 11.00 0.00 2.88 1.75 4.88 1.1816 0.7905 0.226 0.092196
F5 POST 12 12.55 3.01 16.50 6.00 12.08 10.88 15.50 -0.5722 0.6207 0.182 0.313969
F6 PRE 14 11.24 3.89 18.67 5.75 10.92 7.67 13.67 0.3424 -0.9016 0.173 0.295474
F6 ANES 14 11.17 3.10 17.75 7.09 10.21 9.09 13.67 0.5947 -0.2238 0.196 0.150800
F6 HYPO 14 2.34 2.11 6.50 0.00 2.08 0.00 3.34 0.6382 -0.4470 0.160 0.404324
F6 POST 12 11.97 4.14 22.00 6.25 11.92 8.66 13.83 1.1116 2.2859 0.161 0.478054
F7 PRE 14 11.27 4.53 22.17 4.17 11.17 9.09 13.00 0.7397 1.8833 0.179 0.252116
F7 ANES 14 11.40 5.60 22.67 2.84 9.91 8.25 15.17 0.3577 -0.0643 0.170 0.317419
F7 HYPO 14 2.64 2.15 8.34 0.00 2.13 1.67 3.17 1.4779 3.0263 0.241 0.027059
F7 POST 12 12.19 5.95 25.67 2.67 11.00 9.50 14.17 0.9629 1.6882 0.202 0.191201
F8 PRE 14 9.68 6.28 18.50 2.34 10.09 2.67 16.17 0.1670 -1.5994 0.176 0.272732
F8 ANES 14 9.07 5.95 18.67 2.17 8.04 3.75 15.00 0.4741 -1.2452 0.157 0.425740
F8 HYPO 14 2.34 2.79 8.34 0.00 1.75 0.00 3.67 1.0638 0.0931 0.227 0.047844
F8 POST 12 10.87 5.75 19.83 2.50 10.67 5.50 15.17 0.1145 -1.1741 0.118 0.787798
F9 PRE 14 9.61 4.52 16.92 2.00 8.71 6.50 13.83 0.2310 -0.8617 0.160 0.401667
F9 ANES 14 8.97 4.90 16.83 1.75 8.92 5.67 12.84 0.1031 -1.0411 0.105 0.819719
F9 HYPO 14 2.49 2.04 6.75 0.00 2.54 0.00 3.75 0.3830 -0.1286 0.174 0.284217
F9 POST 12 9.92 5.63 18.50 0.00 10.17 6.17 14.92 -0.1247 -0.7480 0.103 0.831940
F10 PRE 14 8.35 4.95 16.17 0.00 8.13 4.50 13.50 -0.0453 -1.0646 0.137 0.607036
F10 ANES 14 8.16 5.75 16.00 0.00 8.25 2.50 13.84 0.0955 -1.6006 0.161 0.393889
F10 HYPO 14 1.66 2.31 6.50 0.00 0.75 0.00 1.75 1.3899 0.7860 0.270 0.006594
F10 POST 12 9.67 4.77 16.00 2.00 10.42 5.75 13.84 -0.4038 -1.1688 0.138 0.663435
F11 PRE 14 5.93 5.53 14.84 0.00 4.79 0.00 11.25 0.2710 -1.6617 0.217 0.071955
F11 ANES 14 7.05 4.93 15.67 0.00 7.88 2.50 9.75 0.1394 -0.8703 0.114 0.776691
F11 HYPO 14 2.36 3.21 9.50 0.00 0.00 0.00 4.50 1.1381 0.3177 0.340 0.000102
F11 POST 12 7.12 5.13 14.67 0.00 7.96 2.25 11.25 -0.3154 -1.2759 0.192 0.249162
Legend: “n”- number of patients; “STD”- standard deviation; “max” - maximum value; “min” - minimum value; “25%” - lower percentile; “75%” - 
upper percentile; “K-S” - Kolmogorov-Smirnov test; F2 - 687 Hz; F3 - 843 Hz; F4 - 1093 Hz; F5 - 1375 Hz; F6 - 1756 Hz; F7 - 2187 Hz; F8 - 2781 
Hz; F9 - 3500 Hz; F10 - 4375 Hz; F11 - 5500 Hz; “PRE” - before surgical procedure; “ANES” - after anesthesia; “HYPO” - after establishment of 
moderate hypothermia; “POST” - after surgery.
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Chart 2. Statistical analysis summary for results of each point in the ’DPgram’ showing statistically significant differences (p<0.05).
 Test used PRE vs. PRÉ X ANESTESIA PRÉ X HIPOTERMIA
POST PRE vs. ANESTHESIA PRE vs. HYPOTHERMIA *** ***
F1 (531 Hz) *** *** *** ***
F2 (687 Hz) Paired T test NO *** ***
F3 (843 Hz) Paired T test NO *** ***
F4 (1093 Hz) One Way... NO NO ***
F5 (1375 Hz) One Way... NO NO YES
F6 (1750 Hz) One Way... NO NO YES
F7 (2187 Hz) One way... NO NO YES
F8 (2781 Hz) One Way... NO NO YES
F9 (3500 Hz) Friedman... NO NO YES
F10 (4375 Hz) One Way... NO NO YES
F11 (5500 Hz) One way... NO NO YES
Legend: “*** “- invalid for analysis; “NO” - statistically insignificant; “yes” - statistically significant; “One Way...” - One way Repeated Measures 
Analysis of variance; “Friedman...”- Friedman Repeated Measures Analysis of Variance on Ranks; “Hz” - Hertz
Graph 1 - “Boxplot” for F2 (687 Hz) - values in dB SPL
Graph 2 - “Boxplot “ for F3 (843 Hz) - values in dB SPL
Graph 3 - “Boxplot “ for F4 (1093 Hz) - values in dB SPL
Graph 4 - “Boxplot “ for F5 (1375 Hz) - values in dB SPL
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Graph 5 - “Boxplot “ for F6 (1750 Hz) - values in dB SPL
Graph 6 - “Boxplot “ for F7 (2187 Hz) - values in dB SPL
Graph 7 - “Boxplot “ for F8 (2781 Hz) - values in dB SPL
Graph 8 - “Boxplot “ for F9 (3500 Hz) - values in dB SPL
Graph 9 - “Boxplot “ for F10 (4375 Hz) - values in dB SPL
Graph 10 - “Boxplot “ for F11 (5500 Hz) - values in dB SPL
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siological patterns and exposes various organs to stress. 
The central nervous system (CNS) is the entity with highest 
exposure to ischemic injury in this context, with risk asses-
sed between 2% and 61%5,30-33. Possible CNS injuries du-
ring surgery include: relatively low effectiveness of blood 
filters; occlusion of the descending aorta; microemboli 
formed from ruptured atherosclerotic plaques or coming 
from dilated heart chambers; air entering the system; fatty 
embolism; coagulation disorders; hypotension; and non-
pulsing flow.
Our patients had increased risk of cochlear damage 
due to advanced age34 and associated diseases (high blood 
pressure, diabetes, and atherosclerosis). Ness et al.4, in a 
large cohort of heart surgery patients, detected pre-op 
auditory disorders in 77% of them. When looking at pa-
pers on post-ECC hearing loss5,35, similar pathophysiologic 
mechanisms associated with CNS injury can be found, the 
main being inner ear hypoperfusion and ischemia. Ho-
wever, there are no pathology findings to support such 
assumptions. Others such as Ness et al.4 have attempted to 
explain post-ECC cochlear injury more as a consequence 
of ototoxic drug use than the surgical procedure itself. 
Meri et al.36 related post-ECC pulmonary complications 
to activation of the complement system, another mecha-
nism that may occur at a cochlear level. Cochlear injury 
consequent to ECC has not been clearly defined. Among 
our patients we could not find subjective (complaints) 
or objective (PRE vs. POST) evidences of cochlear injury 
during ECC, because of two possible reasons. First, the 
DPOAE test may not be sensitive enough to capture it. 
Second, in our group of 14 patients there was no case of 
cochlear injury, as its prevalence is estimated at 0.14%4,5. 
The second hypothesis seems more credible, as the DPOAE 
test is used routinely to monitor cochlear function in other 
circumstances, as mentioned previously.
In 1979, Anderson e Kemp37 demonstrated the oc-
currence of OAEs during general anesthesia in primates. 
DPOAE evaluation in agitated children is routinely done 
under sedation. In a study conducted in humans to assess 
the impact of general anesthesia upon the recording of 
evoked transient OAEs, Hauser et al.38 did not report 
pre or post anesthesia alterations. During anesthesia, 
they reported mild alterations mainly when nitrous oxide 
was being administered. Seifert et al.12, however, did not 
find general anesthesia to have affected the recording of 
evoked transient OAEs. In our study there was no detec-
ted impact of general anesthesia without nitrous oxide on 
the recording of DPOAEs when comparing the PRE vs. 
ANESTHESIA data series.
Coats6 mentioned in 1965 that cats under hypo-
thermia had altered inner ear function as observed in the 
records of cochlear microfonics and action potentials. In 
1985, Doyle and Fria39 reported altered brainstem audio-
metry results in monkeys under hypothermia, a finding 
also confirmed in humans by other authors40,41. Other 
indicators of neurologic and cochlear activity such as 
EEG and P300 tests are also impacted by hypothermia, as 
CNS metabolism decreases along with axonal conduction 
velocity and changes to the synaptic cleft are observed39-42. 
However, the effect of hypothermia on cochlear function 
can be better assessed by looking at OAEs.
In last century’s last decade, several authors looked 
into the effects of hypothermia on the inner ear function 
of various animal models (amphibians, reptiles, birds, 
and mammalians)7-10. We found studies on the impact 
hypothermia has on recording evoked transient OAE in 
humans11, but not DPOAEs. We believe that our study has 
clearly demonstrated the impact hypothermia has upon 
DPOAE based on the comparison between the PRE and 
HYPOTHERMIA data series, where a statistically significant 
amplitude reduction was identified for all points in the 
’DPgram’ deemed valid (F5, F6, F7, F8, F9, F10, F11).
When facing these findings, three possible expla-
nations may be considered: 
1) changes in middle ear impedance during hy-
pothermia hinder DPOAE acquisition in spite of their 
occurrence; 
2) inhibited CNS activity during hypothermia leads 
to altered medial olivocochlear feedback and diminished 
OAE; and 
3) changes in cochlear physiology during hypother-
mia and reduced OHC activity lad to reduced DPOAE.
Seifert et al.12 measured middle ear SPL during 
evoked transient OAE acquisition under hypothermia. 
Evoked transient OAEs disappeared at bodily temperatures 
of approximately 30ºC and middle ear SPL of -177 dPa. As 
the patients were warmed up, they reappeared at -300 dPa. 
Thus, it was concluded that middle ear SPL changes bear 
little significance upon study findings. Lonsbury-Martin et 
al.43 studied patients with normal hearing and detected 
a failure rate of 33% in recording DPOAEs. They resorted 
to tympanometry and stapedial reflex studies but did not 
succeed in correlating the failure rate to alterations in the 
middle ear. Le Bourgeois III et al.29, using animal models 
Graph 11- Comparison between DPOAE averages for each studied 
frequency. Values in dB SPL.
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and looking at tympanic perforations of various sizes, 
were only able to find changes to DPOAE when perilymph 
fistulae were present. Therefore, although it may be said 
that changes in middle ear impedance during hypothermia 
could hinder DPOAE recording, we tend to agree with 
Seifert et al.11 and Kvolves et al.10 and conclude that OAE 
disappearance during hypothermia does not occur by the 
works of such mechanism.
When analyzing the second possible mechanism 
for reduced DPOAE during hypothermia, one must bear 
in mind that the olivocochlear system has marked impact 
upon OHC function40,41. Such impact, however, inhibits 
OHC contraction as activity in the olivocochlear pathway 
is increased in the CNS12,16. Thus, we do not believe that 
diminished CNS activity during hypothermia42 and redu-
ced OHC inhibition by the medial olivocochlear system can 
account for DPOAE amplitude decrease. On the contrary, 
it seems more logical to believe that such fact would even 
facilitate amplitude increases, as is the case in brainstem 
audiometry tracings during mild hypothermia40,41.
We believe that DPOAE amplitude decreases du-
ring hypothermia are related to cochlear alterations and 
decreased OHC activity. According to Seifert et al.12, the 
OHC contraction mechanism that leads to OAE does not 
energetically depend on adenosine triphosphate, but on 
the energy coming from the endocochlear potential. EP 
changes during hypothermia44 may be responsible for 
their decrease. Kvolves et al.10 have also pointed out to 
direct impact of hypothermia upon the OHC contraction 
mechanism.
CONCLUSION
Moderate hypothermia (28º-29ºC) during heart sur-
gery with extracorporeal circulation has led to a decrease in 
the amplitude of distortion product otoacoustic emissions 
in the cohort of patients analyzed.
REFERENCES
 1. Fetterman BL. Distortion-product otoacoustic emissions and cochlear 
microphonics: Relationships in patients with and without endolym-
phatic hydrops. Laryngoscope 2001;111:946-54.
 2. Lonsbury-Martin BL, Martin GK. The clinical utility of distortion-
product otoacoustic emissions. Ear Hear 1990;11(2):144-54.
 3. Perlman HB, Kimura R, Fernandez C. Experiments on the tem-
porary obstruction of the internal auditory artery. Laryngoscope 
1959;69(6):591-613.
 4. Ness J, Stankiewitz J, Kaniff T et al. Sensorineural hearing loss as-
sociated with aortocoronary bypass surgery: a prospective analysis. 
Laryngoscope 1993;103:589-93.
 5. Shapiro MJ, Purn JM, Raskin C. A study of the effects of cardiopulmo-
nary bypass surgery on auditory function. Laryngoscope 1981;91:2046-
52.
 6. Coats AC. Temperature effects on the peripheral auditory apparatus. 
Science 1965;150:1481-3.
 7. Van Dijk P, Wit HP, Segenhout JM. Spontaneous otoacoustic emis-
sions in the European edible frog (Rana esculenta) spectral details 
and temperature dependence. Hear Res 1989;42(2-3):273-82.
 8. Manley GA, Gallo L, Koppl C. Spontaneous otoacoustic emissions in 
two gecko species, Gekko gecko and Eublepharis macularis. J Acoust 
Soc Am 1996;99(3):1588-603.
 9. Taschenberger G, Manley GA. Spontaneous otoacoustic emissions 
in barn owl. Hear Res 1997;110(1-2):61-76.
10. Khovoles R, Freeman S, Sohmer H. Effect of temperature on the 
transient evoked and distortion product otoacoustic emissions in 
rats. Audiol Neurootol 1998;3(6):349-60.
11. Seifert E, Lamprecht-Dinnesen A, Asfour B, et al. The influence of 
body temperature on transient evoked otoacoustic emissions. Br J 
Audiol 1998;32:387-98.
12. Seifert E, Brand K, Van Defleirdt K, et al. The influence of hypother-
mia on outer hair cells of the cochlea and its efferents. Br J Audiol 
2001;35:87-98.
13. Musiek FE, Baran J. Distortion product otoacoustic emissions: hit and 
false-positive rates in normal-hearing and hearing-impaired subjects. 
Am J Otol 1997;18:454-61.
14. Kemp DT. Stimulated acoustic emissions from within the human 
auditory system. J Acoust Soc Am 1978;64(5):1386-91.
15. Brownell WE. Outer hair cell electromotility and otoacoustic emis-
sions. Ear Hear 1990;11(2): 82-92.
16. Veuillet E, Collet L, Duclaux R. Effect of contralateral acoustic stimula-
tion on active cochlear micromechanical properties in human subjects: 
dependence on stimulus variables. J Neurophysiol 1991;65(3):724-
35.
17. Ashmore JF. A fast motile response in guinea-pig outer hair cells: The 
cellular basis of the cochlear amplifier. J Physiol 1987;388: 323-47.
18. Kalinec F, Holley MC, Iwasa KH, et al. A membrane-based force 
generation mechanism in auditory sensory cells. Proc Natl Acad Sci 
1992;89:8671-5.
19. Lonsburry-Martin BL, Whithead ML, Martin GK. Clinical applications 
of otoacoustic emissions. J Speech Hear Res 1991;34:964-81.
20. Probst R, Harris FP. Otoacoustic emissions. In: Alford BR, Jerger J, 
Jenkins HA (eds). Electrophysiologic Evaluation in Otolaryngology. 
Adv Otolaryngol Basel: Karger; 1997. vol 53: 182-204.
21. Beattie RC, Jones RL. Effects of relative levels of the primary tones on 
distortion product otoacoustic emissions in normal-hearing subjects. 
Audiol 1998;37: 187-97.
22. Doyle KJ, Mc Laren CE, Shanks JE, et al. Effects of difluoromethylor-
nithine chemoprevention on audiometry thresholds and otoacoustic 
emissions. Arch Otolaryngol Head Neck Surg 2001;127:553-8.
23. Whitehead ML, Lonsbury-Martin BL, Martin GK. Evidence for two 
discrete sources of 2f1-f2 distortion-product otoacoustic emission in 
rabbit: I. Differential dependence on stimulus parameter. J Acoust 
Soc Am 1992;91(3):1587-607.
24. Berninger E, Gustafsson LL. Changes in 2f1-f2 acoustic distortion 
products in humans during quinine-induced cochlear dysfunction. 
Acta Otolaryngol 2000;120: 600-6.
25. Sockalingam R, Freeman S, Cherny L, et al. Effect of high-dose cis-
platin on auditory brainstem responses and otoacoustic emissions in 
laboratory animals. Am J Otol 2000;21:521-7.
26. Barenäs ML, Holgers KM. Ototoxic Interaction between noise and 
pheomelanin: distortion product otoacoustic emissions after acoustical 
trauma in chloroquine-treated red, black and albino guinea pigs. 
Audiol 2000;39:238-46.
27. Stavroulaki P, Nikolopoulos TP, Psarommatis I, et al. Hearing evalua-
tion with distortion-product otoacoustic emissions in young patients 
undergoing hemodialysis. Clin Otolaryngol 2001;26:235-42.
28. Delgado RE, Ozdamar O, Rahman S, et al. Adaptive noise cancella-
tion in a multimicrophone system for distortion product otoacoustic 
emission acquisition. IEEE Trans Biom Eng 2000;47(9):1154-63.
29. Le Bourgeois III HW, Anand VK, Mc Auley JR, et al. Effect of tympa-
nic perforations on the detection of distortion-product otoacoustic 
emissions. ENT-Ear Nose Throat J 2000;79(8):610-8.
30. Slogoff S, Girgs KZ, Keats AS. Etiologic factors in neuropsychiatric 
complications associated with cardiopulmonary bypass. Anesth 
Analog 1982;61:903-11.
31. Breuer AC, Furlan AJ, Hanson MR et al. Central nervous system 
409
Brazilian Journal of otorhinolaryngology 74 (3) May/June 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
complications of coronary artery bypass graft surgery: a prospective 
analysis of 421 patients. Stroke 1983;14:682-7.
32. Shaw PJ, Bates D, Cartlige NEF, et al. Early neurological complications 
of coronary artery bypass surgery. Br Med J 1985;291:1384-6.
33. Ferry PC. Neurologic sequelae of open heart surgery in children. Am 
J Dis Children 1990;114:369-73.
34. Lonsbury-Martin BL, Harris FP, Stagner BB, et al. Distortion product 
emissions in humans. I. Basicproperties in normally hearing subjects. 
Ann Otol Rhinol Laryngol 1990;99:3-14.
35. Aremberg IK, Allen GW, De Boer A. Sudden deafness immediately 
following cardiopulmonary bypass. J Laryngol Otol 1972;86:73-77.
36. Meri S, Aronen M, Leijala M. Complement activation during cardio-
pulmonary bypass in children. Complement 1988;5:46-54.
37. Anderson SD, Kemp DT. The evoked cochlear mechanical response 
in laboratory primates. Arch Otorhinolaryngol 1979;224:47-54.
38. Hauser R, Probst R, Harris FP, et al. Influence of general anesthesia 
on transiently evoked otoacoustic emissions in humans. Ann Otol 
Rhinol Laryngol 1992;101:994-9.
39. Doyle WJ, Fria TJ. The effects of hypothermia on the latencies of the 
auditory brain-stem response (ABR) in the rhesus monkey. Electroenc 
Clin Neurophysiol 1985;60:258-66.
40. Hett DA, Smith DC, Pilkingston SN, et al. Effect of temperature and 
cardiopulmonary bypass on the auditory evoked response. Br J 
Anaesth 1995;75:293-6.
41. Rodriguez RA, Audenaert SM, Austim III EH, et al. Auditory evoked 
responses in children during cardiopulmonary bypass: report of cases. 
J Clin Neurophysiol 1995;12(2):168-76.
42. Greeley WJ, Hern FH, Ungerleider RM, et al. The effect of hypothermic 
cardiopulmonary bypass and total arrest on cerebral metabolism in 
neonates, infants and children. J Thorac Cardiovasc Surg 1991;101:783-
94.
43. Lonsbury-Martin BL, Harris FP, Stagner BB, et al. Distortion product 
emissions in humans. II. Relations to acoustic immittance and stimulus 
frequency and spontaneous otoacoustic emissions in normally hearing 
subjects. Ann Otol Rhinol Laryngol 1990;99:15-29.
44. Ohlemiller KK, Siegel JH. The effects of moderate cooling on gross 
cochlear potentials in the gerbil: basal and apical differences. Hear 
Res 1992;63:79-89.
